Halozyme Therapeutics Inc. (HALO)
Market Closed
3 Jun, 20:00
$
69. 82
+3.54
+5.34%
$
8.08B Market Cap
20.87 P/E Ratio
- Div Yield
2,144,457 Volume
2.74 Eps
$ 66.28
Previous Close 
Want to track HALO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.63 | - |
| | | 2.15 | - |
| | | 1.63 | - |
| | | 1.24 | - |
| | | 0.97 | 1.11 |
| | | 1.16 | 1.26 |
| | | 0.98 | - |
| | | 0.76 | 0.91 |
| | | 0.7 | 0.79 |
| | | 0.83 | - |
| | | 0.71 | 0.75 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.03 |
| | | - | - |
| | | - | 0.02 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
HALO Earnings Reports FAQ
What is the earnings per share (EPS) for HALO?
The current EPS is 2.74.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 56.25%, reflecting the HALO's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
Halozyme Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Halozyme Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HALO at this time, as Halozyme Therapeutics Inc has no recent EPS data to calculate it.
